Compare ARK Genomic Revolution ETF (ARKG) vs ProShares UltraShort Bloomberg Natural Gas ETF (KOLD) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs ProShares UltraShort Bloomberg Natural Gas ETF — how do they compare? ARK Genomic Revolution ETF trades at $41.25, while ProShares UltraShort Bloomberg Natural Gas ETF trades at $27.98. The key difference: ARK Genomic Revolution ETF is trading nearer its 52-week high, ProShares UltraShort Bloomberg Natural Gas ETF nearer its low. Which is the better fit depends on your goals.
| ARKG | KOLD | |
|---|---|---|
Sector | Sector/Thematic | Leveraged / Inverse |
52-Week High | $43.57 | $49.39 |
52-Week Low | $23.09 | $13.58 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
KOLD is trading at $26.96, up 4.25% with a bullish technical signal supported by moving averages. The stock faces resistance at $27-$29 while finding support at $25-$23 levels. Recent natural gas market volatility driven by weather patterns and LNG demand creates trading opportunities for this bearish natural gas ETF. The RSI at 73.40 indicates potential overbought conditions near-term.
As a tactical trading instrument, KOLD offers exposure to inverse natural gas price movements amid heightened energy market volatility. Key catalysts include weather-driven demand shifts and geopolitical developments affecting LNG exports. Risk factors include sudden natural gas price spikes and changing supply-demand dynamics that could pressure the fund's inverse positioning.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About ProShares UltraShort Bloomberg Natural Gas ETF
KOLD is an inverse leveraged ETF that seeks to provide two times (2x) the inverse daily performance of the Bloomberg Natural Gas Subindex. It is designed for investors looking to profit from falling natural gas prices.
Read more on KOLD →
